{"entity":{"type":"insider","cik":"0001537529","url":"/insider/0001537529","json_url":"/insider/0001537529.json","name":"Monia Brett P","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":100,"n_filings":66,"first":"2012-07-03","last":"2026-06-26","span_basis":"filed_date"},"name_variants":[{"name":"Monia Brett P","source":"filing","n_filings":66,"first_seen":"2012-07-03","last_seen":"2026-06-26"}],"transactions":[{"id":5891556,"accession":"0000874015-26-000212","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000874015-26-000212","line_url":"/filing/0000874015-26-000212#line-6","is_derivative":false,"issuer_cik":"0000874015","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0000874015","owner_cik":"0001537529","owner_name":"Monia Brett P","owner_display_name":"Monia Brett P","owner_url":"/insider/0001537529","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":80.59,"price_display":"80.59","price_state":"stated","total_value":4029500.0,"total_display":"4,029,500.00","total_whole":"4,029,500","shares_owned_after":245571.0,"shares_owned_after_display":"245,571","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-26","filed_date":"2026-06-26","scope":"insider"},{"id":5891552,"accession":"0000874015-26-000212","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000874015-26-000212","line_url":"/filing/0000874015-26-000212#line-4","is_derivative":false,"issuer_cik":"0000874015","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0000874015","owner_cik":"0001537529","owner_name":"Monia Brett P","owner_display_name":"Monia Brett P","owner_url":"/insider/0001537529","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":21072.0,"shares_display":"21,072","price_per_share":78.49,"price_display":"78.49","price_state":"stated","total_value":1653941.28,"total_display":"1,653,941.28","total_whole":"1,653,941","shares_owned_after":245571.0,"shares_owned_after_display":"245,571","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-25","filed_date":"2026-06-26","scope":"insider"},{"id":5891548,"accession":"0000874015-26-000212","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000874015-26-000212","line_url":"/filing/0000874015-26-000212#line-2","is_derivative":false,"issuer_cik":"0000874015","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0000874015","owner_cik":"0001537529","owner_name":"Monia Brett P","owner_display_name":"Monia Brett P","owner_url":"/insider/0001537529","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14565.0,"shares_display":"14,565","price_per_share":78.4128,"price_display":"78.41","price_state":"stated","total_value":1142082.432,"total_display":"1,142,082.43","total_whole":"1,142,082","shares_owned_after":245571.0,"shares_owned_after_display":"245,571","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-24","filed_date":"2026-06-26","scope":"insider"},{"id":5842675,"accession":"0000874015-26-000185","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000874015-26-000185","line_url":"/filing/0000874015-26-000185#line-4","is_derivative":false,"issuer_cik":"0000874015","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0000874015","owner_cik":"0001537529","owner_name":"Monia Brett P","owner_display_name":"Monia Brett P","owner_url":"/insider/0001537529","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3220.0,"shares_display":"3,220","price_per_share":78.6793,"price_display":"78.68","price_state":"stated","total_value":253347.346,"total_display":"253,347.35","total_whole":"253,347","shares_owned_after":242662.0,"shares_owned_after_display":"242,662","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-14","filed_date":"2026-05-15","scope":"insider"},{"id":5842671,"accession":"0000874015-26-000185","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000874015-26-000185","line_url":"/filing/0000874015-26-000185#line-2","is_derivative":false,"issuer_cik":"0000874015","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0000874015","owner_cik":"0001537529","owner_name":"Monia Brett P","owner_display_name":"Monia Brett P","owner_url":"/insider/0001537529","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1316.0,"shares_display":"1,316","price_per_share":78.013,"price_display":"78.01","price_state":"stated","total_value":102665.108,"total_display":"102,665.11","total_whole":"102,665","shares_owned_after":242662.0,"shares_owned_after_display":"242,662","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-13","filed_date":"2026-05-15","scope":"insider"},{"id":5854739,"accession":"0000874015-26-000143","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0000874015-26-000143","line_url":"/filing/0000874015-26-000143","is_derivative":false,"issuer_cik":"0000874015","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0000874015","owner_cik":"0001537529","owner_name":"Monia Brett P","owner_display_name":"Monia Brett P","owner_url":"/insider/0001537529","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":34103.0,"shares_display":"34,103","price_per_share":75.9213030437205,"price_display":"75.92","price_state":"stated","total_value":2589144.1977,"total_display":"2,589,144.20","total_whole":"2,589,144","shares_owned_after":242662.0,"shares_owned_after_display":"242,662","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-10","filed_date":"2026-03-11","scope":"insider","n_lines":2},{"id":5854734,"accession":"0000874015-26-000143","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000874015-26-000143","line_url":"/filing/0000874015-26-000143","is_derivative":false,"issuer_cik":"0000874015","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0000874015","owner_cik":"0001537529","owner_name":"Monia Brett P","owner_display_name":"Monia Brett P","owner_url":"/insider/0001537529","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":126670.0,"shares_display":"126,670","price_per_share":75.19547648219783,"price_display":"75.20","price_state":"stated","total_value":9525011.006,"total_display":"9,525,011.01","total_whole":"9,525,011","shares_owned_after":244346.0,"shares_owned_after_display":"244,346","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-09","filed_date":"2026-03-11","scope":"insider","n_lines":3},{"id":5936759,"accession":"0000874015-26-000106","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000874015-26-000106","line_url":"/filing/0000874015-26-000106#line-1","is_derivative":false,"issuer_cik":"0000874015","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0000874015","owner_cik":"0001537529","owner_name":"Monia Brett P","owner_display_name":"Monia Brett P","owner_url":"/insider/0001537529","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":29430.0,"shares_display":"29,430","price_per_share":85.7907,"price_display":"85.79","price_state":"stated","total_value":2524820.301,"total_display":"2,524,820.30","total_whole":"2,524,820","shares_owned_after":254497.0,"shares_owned_after_display":"254,497","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-06","filed_date":"2026-02-10","scope":"insider"},{"id":5817390,"accession":"0000874015-26-000099","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000874015-26-000099","line_url":"/filing/0000874015-26-000099#line-2","is_derivative":false,"issuer_cik":"0000874015","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0000874015","owner_cik":"0001537529","owner_name":"Monia Brett P","owner_display_name":"Monia Brett P","owner_url":"/insider/0001537529","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":62970.0,"shares_display":"62,970","price_per_share":82.7216,"price_display":"82.72","price_state":"stated","total_value":5208979.152,"total_display":"5,208,979.15","total_whole":"5,208,979","shares_owned_after":283927.0,"shares_owned_after_display":"283,927","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-30","filed_date":"2026-02-02","scope":"insider"},{"id":5914534,"accession":"0000874015-26-000069","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000874015-26-000069","line_url":"/filing/0000874015-26-000069#line-2","is_derivative":false,"issuer_cik":"0000874015","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0000874015","owner_cik":"0001537529","owner_name":"Monia Brett P","owner_display_name":"Monia Brett P","owner_url":"/insider/0001537529","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":44034.0,"shares_display":"44,034","price_per_share":74.82,"price_display":"74.82","price_state":"stated","total_value":3294623.88,"total_display":"3,294,623.88","total_whole":"3,294,624","shares_owned_after":224683.0,"shares_owned_after_display":"224,683","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-16","filed_date":"2026-01-20","scope":"insider"},{"id":4572908,"accession":"0000874015-25-000252","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000874015-25-000252","line_url":"/filing/0000874015-25-000252#line-1","is_derivative":false,"issuer_cik":"0000874015","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0000874015","owner_cik":"0001537529","owner_name":"Monia Brett P","owner_display_name":"Monia Brett P","owner_url":"/insider/0001537529","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":437.0,"shares_display":"437","price_per_share":69.2637,"price_display":"69.26","price_state":"stated","total_value":30268.2369,"total_display":"30,268.24","total_whole":"30,268","shares_owned_after":179572.0,"shares_owned_after_display":"179,572","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-06","filed_date":"2025-10-08","scope":"insider"},{"id":4126150,"accession":"0000874015-25-000221","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0000874015-25-000221","line_url":"/filing/0000874015-25-000221","is_derivative":false,"issuer_cik":"0000874015","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0000874015","owner_cik":"0001537529","owner_name":"Monia Brett P","owner_display_name":"Monia Brett P","owner_url":"/insider/0001537529","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":203814.0,"shares_display":"203,814","price_per_share":60.32315249246862,"price_display":"60.32","price_state":"stated","total_value":12294703.0021,"total_display":"12,294,703.00","total_whole":"12,294,703","shares_owned_after":180824.0,"shares_owned_after_display":"180,824","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-03","filed_date":"2025-09-04","scope":"insider","n_lines":3},{"id":4057879,"accession":"0000874015-25-000170","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000874015-25-000170","line_url":"/filing/0000874015-25-000170#line-2","is_derivative":false,"issuer_cik":"0000874015","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0000874015","owner_cik":"0001537529","owner_name":"Monia Brett P","owner_display_name":"Monia Brett P","owner_url":"/insider/0001537529","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2432.0,"shares_display":"2,432","price_per_share":45.0,"price_display":"45.00","price_state":"stated","total_value":109440.0,"total_display":"109,440.00","total_whole":"109,440","shares_owned_after":179820.0,"shares_owned_after_display":"179,820","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-07-30","filed_date":"2025-08-01","scope":"insider"},{"id":4451740,"accession":"0000874015-25-000146","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000874015-25-000146","line_url":"/filing/0000874015-25-000146#line-1","is_derivative":false,"issuer_cik":"0000874015","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0000874015","owner_cik":"0001537529","owner_name":"Monia Brett P","owner_display_name":"Monia Brett P","owner_url":"/insider/0001537529","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1160.0,"shares_display":"1,160","price_per_share":41.7381,"price_display":"41.74","price_state":"stated","total_value":48416.196,"total_display":"48,416.20","total_whole":"48,416","shares_owned_after":179820.0,"shares_owned_after_display":"179,820","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-07-11","filed_date":"2025-07-15","scope":"insider"},{"id":4746234,"accession":"0000874015-25-000105","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000874015-25-000105","line_url":"/filing/0000874015-25-000105#line-1","is_derivative":false,"issuer_cik":"0000874015","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0000874015","owner_cik":"0001537529","owner_name":"Monia Brett P","owner_display_name":"Monia Brett P","owner_url":"/insider/0001537529","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":140.0,"shares_display":"140","price_per_share":32.32,"price_display":"32.32","price_state":"stated","total_value":4524.8,"total_display":"4,524.80","total_whole":"4,525","shares_owned_after":180980.0,"shares_owned_after_display":"180,980","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-11","filed_date":"2025-03-13","scope":"insider"},{"id":4368768,"accession":"0000874015-25-000084","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000874015-25-000084","line_url":"/filing/0000874015-25-000084#line-1","is_derivative":false,"issuer_cik":"0000874015","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0000874015","owner_cik":"0001537529","owner_name":"Monia Brett P","owner_display_name":"Monia Brett P","owner_url":"/insider/0001537529","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":38843.0,"shares_display":"38,843","price_per_share":31.6521,"price_display":"31.65","price_state":"stated","total_value":1229462.5203,"total_display":"1,229,462.52","total_whole":"1,229,463","shares_owned_after":180683.0,"shares_owned_after_display":"180,683","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-04","filed_date":"2025-02-06","scope":"insider"},{"id":4746232,"accession":"0000874015-25-000078","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000874015-25-000078","line_url":"/filing/0000874015-25-000078#line-2","is_derivative":false,"issuer_cik":"0000874015","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0000874015","owner_cik":"0001537529","owner_name":"Monia Brett P","owner_display_name":"Monia Brett P","owner_url":"/insider/0001537529","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13242.0,"shares_display":"13,242","price_per_share":32.4464,"price_display":"32.45","price_state":"stated","total_value":429655.2288,"total_display":"429,655.23","total_whole":"429,655","shares_owned_after":219526.0,"shares_owned_after_display":"219,526","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-31","filed_date":"2025-02-03","scope":"insider"},{"id":4656489,"accession":"0000874015-25-000062","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000874015-25-000062","line_url":"/filing/0000874015-25-000062#line-2","is_derivative":false,"issuer_cik":"0000874015","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0000874015","owner_cik":"0001537529","owner_name":"Monia Brett P","owner_display_name":"Monia Brett P","owner_url":"/insider/0001537529","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":33445.0,"shares_display":"33,445","price_per_share":32.634,"price_display":"32.63","price_state":"stated","total_value":1091444.13,"total_display":"1,091,444.13","total_whole":"1,091,444","shares_owned_after":207396.0,"shares_owned_after_display":"207,396","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-16","filed_date":"2025-01-17","scope":"insider"},{"id":2815849,"accession":"0000874015-24-000240","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000874015-24-000240","line_url":"/filing/0000874015-24-000240#line-1","is_derivative":false,"issuer_cik":"0000874015","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0000874015","owner_cik":"0001537529","owner_name":"Monia Brett P","owner_display_name":"Monia Brett P","owner_url":"/insider/0001537529","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6630.0,"shares_display":"6,630","price_per_share":38.0534,"price_display":"38.05","price_state":"stated","total_value":252294.042,"total_display":"252,294.04","total_whole":"252,294","shares_owned_after":167393.0,"shares_owned_after_display":"167,393","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-12","filed_date":"2024-11-14","scope":"insider"},{"id":2763532,"accession":"0000874015-24-000112","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000874015-24-000112","line_url":"/filing/0000874015-24-000112#line-1","is_derivative":false,"issuer_cik":"0000874015","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0000874015","owner_cik":"0001537529","owner_name":"Monia Brett P","owner_display_name":"Monia Brett P","owner_url":"/insider/0001537529","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":387.0,"shares_display":"387","price_per_share":44.4924,"price_display":"44.49","price_state":"stated","total_value":17218.5588,"total_display":"17,218.56","total_whole":"17,219","shares_owned_after":173751.0,"shares_owned_after_display":"173,751","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-16","filed_date":"2024-02-16","scope":"insider"},{"id":9201494,"accession":"0000874015-24-000195","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000874015-24-000195","line_url":"/filing/0000874015-24-000195#line-1","is_derivative":false,"issuer_cik":"0000874015","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0000874015","owner_cik":"0001537529","owner_name":"Monia Brett P","owner_display_name":"Monia Brett P","owner_url":"/insider/0001537529","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":23907.0,"shares_display":"23,907","price_per_share":49.3725,"price_display":"49.37","price_state":"stated","total_value":1180348.3575,"total_display":"1,180,348.36","total_whole":"1,180,348","shares_owned_after":173732.0,"shares_owned_after_display":"173,732","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-02","filed_date":"2024-09-04","scope":"insider"},{"id":9201491,"accession":"0000874015-24-000192","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000874015-24-000192","line_url":"/filing/0000874015-24-000192#line-1","is_derivative":false,"issuer_cik":"0000874015","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0000874015","owner_cik":"0001537529","owner_name":"Monia Brett P","owner_display_name":"Monia Brett P","owner_url":"/insider/0001537529","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":23907.0,"shares_display":"23,907","price_per_share":49.3725,"price_display":"49.37","price_state":"stated","total_value":1180348.3575,"total_display":"1,180,348.36","total_whole":"1,180,348","shares_owned_after":173732.0,"shares_owned_after_display":"173,732","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-02","filed_date":"2024-09-04","scope":"insider"},{"id":2884052,"accession":"0000874015-24-000107","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000874015-24-000107","line_url":"/filing/0000874015-24-000107#line-3","is_derivative":false,"issuer_cik":"0000874015","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0000874015","owner_cik":"0001537529","owner_name":"Monia Brett P","owner_display_name":"Monia Brett P","owner_url":"/insider/0001537529","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":23501.0,"shares_display":"23,501","price_per_share":49.3725,"price_display":"49.37","price_state":"stated","total_value":1160303.1225,"total_display":"1,160,303.12","total_whole":"1,160,303","shares_owned_after":174138.0,"shares_owned_after_display":"174,138","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-02","filed_date":"2024-02-02","scope":"insider"},{"id":3198039,"accession":"0000874015-24-000085","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000874015-24-000085","line_url":"/filing/0000874015-24-000085#line-1","is_derivative":false,"issuer_cik":"0000874015","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0000874015","owner_cik":"0001537529","owner_name":"Monia Brett P","owner_display_name":"Monia Brett P","owner_url":"/insider/0001537529","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2285.0,"shares_display":"2,285","price_per_share":51.75,"price_display":"51.75","price_state":"stated","total_value":118248.75,"total_display":"118,248.75","total_whole":"118,249","shares_owned_after":151851.0,"shares_owned_after_display":"151,851","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-25","filed_date":"2024-01-29","scope":"insider"},{"id":2034969,"accession":"0000874015-24-000076","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000874015-24-000076","line_url":"/filing/0000874015-24-000076#line-2","is_derivative":false,"issuer_cik":"0000874015","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0000874015","owner_cik":"0001537529","owner_name":"Monia Brett P","owner_display_name":"Monia Brett P","owner_url":"/insider/0001537529","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":32059.0,"shares_display":"32,059","price_per_share":50.417,"price_display":"50.42","price_state":"stated","total_value":1616318.603,"total_display":"1,616,318.60","total_whole":"1,616,319","shares_owned_after":154136.0,"shares_owned_after_display":"154,136","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-17","filed_date":"2024-01-18","scope":"insider"},{"id":7833432,"accession":"0000874015-23-000234","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000874015-23-000234","line_url":"/filing/0000874015-23-000234#line-4","is_derivative":false,"issuer_cik":"0000874015","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0000874015","owner_cik":"0001537529","owner_name":"Monia Brett P","owner_display_name":"Monia Brett P","owner_url":"/insider/0001537529","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17500.0,"shares_display":"17,500","price_per_share":49.2901,"price_display":"49.29","price_state":"stated","total_value":862576.75,"total_display":"862,576.75","total_whole":"862,577","shares_owned_after":118111.0,"shares_owned_after_display":"118,111","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-21","filed_date":"2023-12-22","scope":"insider"},{"id":7833428,"accession":"0000874015-23-000234","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000874015-23-000234","line_url":"/filing/0000874015-23-000234#line-2","is_derivative":false,"issuer_cik":"0000874015","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0000874015","owner_cik":"0001537529","owner_name":"Monia Brett P","owner_display_name":"Monia Brett P","owner_url":"/insider/0001537529","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6500.0,"shares_display":"6,500","price_per_share":49.6374,"price_display":"49.64","price_state":"stated","total_value":322643.1,"total_display":"322,643.10","total_whole":"322,643","shares_owned_after":118111.0,"shares_owned_after_display":"118,111","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-20","filed_date":"2023-12-22","scope":"insider"},{"id":7854210,"accession":"0000874015-23-000228","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000874015-23-000228","line_url":"/filing/0000874015-23-000228","is_derivative":false,"issuer_cik":"0000874015","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0000874015","owner_cik":"0001537529","owner_name":"Monia Brett P","owner_display_name":"Monia Brett P","owner_url":"/insider/0001537529","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":24000.0,"shares_display":"24,000","price_per_share":49.584117416666665,"price_display":"49.58","price_state":"stated","total_value":1190018.818,"total_display":"1,190,018.82","total_whole":"1,190,019","shares_owned_after":118111.0,"shares_owned_after_display":"118,111","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-14","filed_date":"2023-12-18","scope":"insider","n_lines":2},{"id":8061669,"accession":"0000874015-23-000201","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000874015-23-000201","line_url":"/filing/0000874015-23-000201#line-1","is_derivative":false,"issuer_cik":"0000874015","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0000874015","owner_cik":"0001537529","owner_name":"Monia Brett P","owner_display_name":"Monia Brett P","owner_url":"/insider/0001537529","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3770.0,"shares_display":"3,770","price_per_share":46.0,"price_display":"46.00","price_state":"stated","total_value":173420.0,"total_display":"173,420.00","total_whole":"173,420","shares_owned_after":118111.0,"shares_owned_after_display":"118,111","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-10-12","filed_date":"2023-10-16","scope":"insider"},{"id":8505646,"accession":"0000874015-23-000163","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000874015-23-000163","line_url":"/filing/0000874015-23-000163#line-1","is_derivative":false,"issuer_cik":"0000874015","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0000874015","owner_cik":"0001537529","owner_name":"Monia Brett P","owner_display_name":"Monia Brett P","owner_url":"/insider/0001537529","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18650.0,"shares_display":"18,650","price_per_share":42.2495,"price_display":"42.25","price_state":"stated","total_value":787953.175,"total_display":"787,953.18","total_whole":"787,953","shares_owned_after":121724.0,"shares_owned_after_display":"121,724","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-07","filed_date":"2023-07-11","scope":"insider"},{"id":8309181,"accession":"0000874015-23-000139","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000874015-23-000139","line_url":"/filing/0000874015-23-000139","is_derivative":false,"issuer_cik":"0000874015","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0000874015","owner_cik":"0001537529","owner_name":"Monia Brett P","owner_display_name":"Monia Brett P","owner_url":"/insider/0001537529","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4931.0,"shares_display":"4,931","price_per_share":40.135333603731496,"price_display":"40.14","price_state":"stated","total_value":197907.33,"total_display":"197,907.33","total_whole":"197,907","shares_owned_after":140374.0,"shares_owned_after_display":"140,374","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-22","filed_date":"2023-05-24","scope":"insider","n_lines":2},{"id":8387333,"accession":"0000874015-23-000093","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000874015-23-000093","line_url":"/filing/0000874015-23-000093#line-4","is_derivative":false,"issuer_cik":"0000874015","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0000874015","owner_cik":"0001537529","owner_name":"Monia Brett P","owner_display_name":"Monia Brett P","owner_url":"/insider/0001537529","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":24651.0,"shares_display":"24,651","price_per_share":40.6942,"price_display":"40.69","price_state":"stated","total_value":1003152.7242,"total_display":"1,003,152.72","total_whole":"1,003,153","shares_owned_after":145305.0,"shares_owned_after_display":"145,305","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-06","filed_date":"2023-02-07","scope":"insider"},{"id":7961195,"accession":"0000874015-23-000066","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000874015-23-000066","line_url":"/filing/0000874015-23-000066#line-2","is_derivative":false,"issuer_cik":"0000874015","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0000874015","owner_cik":"0001537529","owner_name":"Monia Brett P","owner_display_name":"Monia Brett P","owner_url":"/insider/0001537529","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25066.0,"shares_display":"25,066","price_per_share":39.4936,"price_display":"39.49","price_state":"stated","total_value":989946.5776,"total_display":"989,946.58","total_whole":"989,947","shares_owned_after":120863.0,"shares_owned_after_display":"120,863","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-18","filed_date":"2023-01-19","scope":"insider"},{"id":6116392,"accession":"0000874015-22-000093","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000874015-22-000093","line_url":"/filing/0000874015-22-000093#line-1","is_derivative":false,"issuer_cik":"0000874015","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0000874015","owner_cik":"0001537529","owner_name":"Monia Brett P","owner_display_name":"Monia Brett P","owner_url":"/insider/0001537529","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":355.0,"shares_display":"355","price_per_share":37.4901,"price_display":"37.49","price_state":"stated","total_value":13308.9855,"total_display":"13,308.99","total_whole":"13,309","shares_owned_after":88662.0,"shares_owned_after_display":"88,662","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-04-01","filed_date":"2022-04-05","scope":"insider"},{"id":4972307,"accession":"0000874015-21-000058","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000874015-21-000058","line_url":"/filing/0000874015-21-000058#line-2","is_derivative":false,"issuer_cik":"0000874015","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0000874015","owner_cik":"0001537529","owner_name":"Monia Brett P","owner_display_name":"Monia Brett P","owner_url":"/insider/0001537529","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":236.0,"shares_display":"236","price_per_share":54.275,"price_display":"54.28","price_state":"stated","total_value":12808.9,"total_display":"12,808.90","total_whole":"12,809","shares_owned_after":50114.0,"shares_owned_after_display":"50,114","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-01","filed_date":"2021-03-02","scope":"insider"},{"id":3109744,"accession":"0000874015-20-000168","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000874015-20-000168","line_url":"/filing/0000874015-20-000168#line-2","is_derivative":false,"issuer_cik":"0000874015","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0000874015","owner_cik":"0001537529","owner_name":"Monia Brett P","owner_display_name":"Monia Brett P","owner_url":"/insider/0001537529","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":23840.0,"shares_display":"23,840","price_per_share":51.04,"price_display":"51.04","price_state":"stated","total_value":1216793.6,"total_display":"1,216,793.60","total_whole":"1,216,794","shares_owned_after":28879.0,"shares_owned_after_display":"28,879","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-04","filed_date":"2020-12-08","scope":"insider"},{"id":2676502,"accession":"0000874015-20-000162","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000874015-20-000162","line_url":"/filing/0000874015-20-000162#line-2","is_derivative":false,"issuer_cik":"0000874015","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0000874015","owner_cik":"0001537529","owner_name":"Monia Brett P","owner_display_name":"Monia Brett P","owner_url":"/insider/0001537529","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":21160.0,"shares_display":"21,160","price_per_share":51.32,"price_display":"51.32","price_state":"stated","total_value":1085931.2,"total_display":"1,085,931.20","total_whole":"1,085,931","shares_owned_after":28879.0,"shares_owned_after_display":"28,879","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-02","filed_date":"2020-12-04","scope":"insider"},{"id":2676492,"accession":"0000874015-20-000121","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000874015-20-000121","line_url":"/filing/0000874015-20-000121#line-2","is_derivative":false,"issuer_cik":"0000874015","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0000874015","owner_cik":"0001537529","owner_name":"Monia Brett P","owner_display_name":"Monia Brett P","owner_url":"/insider/0001537529","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":314.0,"shares_display":"314","price_per_share":53.7,"price_display":"53.70","price_state":"stated","total_value":16861.8,"total_display":"16,861.80","total_whole":"16,862","shares_owned_after":28879.0,"shares_owned_after_display":"28,879","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-09-01","filed_date":"2020-09-02","scope":"insider"},{"id":2951494,"accession":"0000874015-20-000014","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000874015-20-000014","line_url":"/filing/0000874015-20-000014#line-1","is_derivative":false,"issuer_cik":"0000874015","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0000874015","owner_cik":"0001537529","owner_name":"Monia Brett P","owner_display_name":"Monia Brett P","owner_url":"/insider/0001537529","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":173.0,"shares_display":"173","price_per_share":60.25,"price_display":"60.25","price_state":"stated","total_value":10423.25,"total_display":"10,423.25","total_whole":"10,423","shares_owned_after":16285.0,"shares_owned_after_display":"16,285","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-01-02","filed_date":"2020-01-03","scope":"insider"},{"id":7878734,"accession":"0000874015-19-000135","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000874015-19-000135","line_url":"/filing/0000874015-19-000135#line-1","is_derivative":false,"issuer_cik":"0000874015","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0000874015","owner_cik":"0001537529","owner_name":"Monia Brett P","owner_display_name":"Monia Brett P","owner_url":"/insider/0001537529","role":"Director, Officer (COO & SVP, Translational Med)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"COO & SVP, Translational Med","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5776.0,"shares_display":"5,776","price_per_share":60.01,"price_display":"60.01","price_state":"stated","total_value":346617.76,"total_display":"346,617.76","total_whole":"346,618","shares_owned_after":16458.0,"shares_owned_after_display":"16,458","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-11-20","filed_date":"2019-11-21","scope":"insider"},{"id":8339037,"accession":"0000874015-19-000089","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000874015-19-000089","line_url":"/filing/0000874015-19-000089#line-2","is_derivative":false,"issuer_cik":"0000874015","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0000874015","owner_cik":"0001537529","owner_name":"Monia Brett P","owner_display_name":"Monia Brett P","owner_url":"/insider/0001537529","role":"Director, Officer (Chief Operating Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":210.0,"shares_display":"210","price_per_share":66.4,"price_display":"66.40","price_state":"stated","total_value":13944.0,"total_display":"13,944.00","total_whole":"13,944","shares_owned_after":22234.0,"shares_owned_after_display":"22,234","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-07-02","filed_date":"2019-07-02","scope":"insider"},{"id":8757154,"accession":"0000874015-19-000009","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000874015-19-000009","line_url":"/filing/0000874015-19-000009#line-2","is_derivative":false,"issuer_cik":"0000874015","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0000874015","owner_cik":"0001537529","owner_name":"Monia Brett P","owner_display_name":"Monia Brett P","owner_url":"/insider/0001537529","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":214.0,"shares_display":"214","price_per_share":53.5,"price_display":"53.50","price_state":"stated","total_value":11449.0,"total_display":"11,449.00","total_whole":"11,449","shares_owned_after":15837.0,"shares_owned_after_display":"15,837","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-01-02","filed_date":"2019-01-03","scope":"insider"},{"id":6282330,"accession":"0000874015-18-000130","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000874015-18-000130","line_url":"/filing/0000874015-18-000130#line-2","is_derivative":false,"issuer_cik":"0000874015","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONIS","issuer_name_source":null,"issuer_url":"/issuer/0000874015","owner_cik":"0001537529","owner_name":"Monia Brett P","owner_display_name":"Monia Brett P","owner_url":"/insider/0001537529","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":34000.0,"shares_display":"34,000","price_per_share":55.0017,"price_display":"55.00","price_state":"stated","total_value":1870057.8,"total_display":"1,870,057.80","total_whole":"1,870,058","shares_owned_after":15841.0,"shares_owned_after_display":"15,841","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-11-23","filed_date":"2018-11-26","scope":"insider"}],"collapsed":true,"next_cursor":"2018-11-23|6282330","ledger_fault":false,"count":{"value":100,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":100,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":100},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000874015","name":"IONIS PHARMACEUTICALS INC","url":"/issuer/0000874015","role":"Director, Officer (Chief Executive Officer)","n_filings":66,"first_seen":"2012-07-03","last_seen":"2026-06-26"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001537529","retrieved_at":"2026-08-23T03:17:24+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}